Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19

Gavin D Perkins, Chen Ji, Bronwen A Connolly, Keith Couper, Ranjit Lall, J Kenneth Baillie, Judy M Bradley, Paul Dark, Chirag Dave, Anthony De Soyza, Anna V Dennis, Anne Devrell, Sara Fairbairn, Hakim Ghani, Ellen A Gorman, Christopher A Green, Nicholas Hart, Siew Wan Hee, Zoe Kimbley, Shyam Madathil, Nicola McGowan, Benjamin Messer, Jay Naisbitt, Chloe Norman, Dhruv Parekh, Emma M Parkin, Jaimin Patel, Scott E Regan, Clare Ross, Anthony J Rostron, Mohammad Saim, Anita K Simonds, Emma Skilton, Nigel Stallard, Michael Steiner, Rama Vancheeswaran, Joyce Yeung, Daniel F McAuley On behalf of the Recovery- RS collaborators
doi: https://doi.org/10.1101/2021.08.02.21261379
Gavin D Perkins
1Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
2University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chen Ji
1Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bronwen A Connolly
3Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Science, Queen’s University Belfast, Belfast, UK
4Lane Fox Clinical Respiratory Physiology Research Centre, Guy’s and St.Thomas’ NHS Foundation Trust, London, UK
5Centre for Human and Applied Physiological Sciences, King’s College London, UK
6Department of Physiotherapy, The University of Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith Couper
1Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
2University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ranjit Lall
1Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Kenneth Baillie
7Roslin Institute, University of Edinburgh, Midlothian, UK
8MRC Human Genetics Unit, Institute for Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
9Intensive Care Unit, Royal Infirmary of Edinburgh, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judy M Bradley
3Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Science, Queen’s University Belfast, Belfast, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Dark
10NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, UK
11Salford Royal Hospital, Northern Care Alliance NHS Group, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chirag Dave
2University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony De Soyza
12Population and Health Science Institute, NIHR Biomedical Research Centre, Newcastle, University, Newcastle Upon Tyne, UK
13Newcastle-Upon-Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna V Dennis
2University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Devrell
1Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
14Research Champion Team, West Midlands Clinical Research Network, Wolverhampton, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Fairbairn
15Grange University Hospital, Aneurin Bevan University Health Board, Cwmbran, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hakim Ghani
16Watford General Hospital, West Hertfordshire Hospitals NHS Trust, Watford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ellen A Gorman
3Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Science, Queen’s University Belfast, Belfast, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher A Green
2University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Hart
4Lane Fox Clinical Respiratory Physiology Research Centre, Guy’s and St.Thomas’ NHS Foundation Trust, London, UK
5Centre for Human and Applied Physiological Sciences, King’s College London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siew Wan Hee
18Fairfield General Hospital, Pennine Acute Hospitals NHS Trust, Northern Care Alliance NHS Group, Bury, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zoe Kimbley
2University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shyam Madathil
2University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicola McGowan
1Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Messer
13Newcastle-Upon-Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jay Naisbitt
18Fairfield General Hospital, Pennine Acute Hospitals NHS Trust, Northern Care Alliance NHS Group, Bury, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chloe Norman
1Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dhruv Parekh
2University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
19Institute of Inflammation and Ageing, School of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma M Parkin
18Fairfield General Hospital, Pennine Acute Hospitals NHS Trust, Northern Care Alliance NHS Group, Bury, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaimin Patel
2University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
19Institute of Inflammation and Ageing, School of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott E Regan
1Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clare Ross
21Sunderland Royal Hospital, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony J Rostron
21Sunderland Royal Hospital, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK
22Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad Saim
2University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anita K Simonds
23Royal Brompton & Harefield Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Skilton
1Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigel Stallard
17Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Steiner
24Institute for Lung Health, NIHR BRC Respiratory Medicine, Department of Respiratory Sciences, University of Leicester, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rama Vancheeswaran
16Watford General Hospital, West Hertfordshire Hospitals NHS Trust, Watford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joyce Yeung
1Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
2University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel F McAuley
3Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Science, Queen’s University Belfast, Belfast, UK
25Royal Victoria Hospital, Belfast, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: d.f.mcauley@qub.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Both continuous positive airway pressure (CPAP) and high-flow nasal oxygenation (HFNO) have been recommended for acute respiratory failure in COVID-19. However, uncertainty exists regarding effectiveness and safety.

Methods In the Recovery-Respiratory Support multi-center, three-arm, open-label, adaptive, randomized controlled trial, adult hospitalized patients with acute respiratory failure due to COVID-19, deemed suitable for treatment escalation, were randomly assigned to receive CPAP, HFNO, or conventional oxygen therapy. Comparisons were made between each intervention and conventional oxygen therapy. The primary outcome was a composite of tracheal intubation or mortality within 30-days.

Results Over 13-months, 1272 participants were randomized and included in the analysis (380 (29.9%) CPAP; 417 (32.8%) HFNO; 475 (37.3%) conventional oxygen therapy). The need for tracheal intubation or mortality within 30-days was lower in the CPAP group (CPAP 137 of 377 participants (36.3%) vs conventional oxygen therapy 158 of 356 participants (44.4%); unadjusted odds ratio 0.72; 95% CI 0.53 to 0.96, P=0.03). There was no difference between HFNO and conventional oxygen therapy (HFNO 184 of 414 participants (44.4%) vs conventional oxygen therapy 166 of 368 participants (45.1%); unadjusted odds ratio 0.97; 95% CI 0.73 to 1.29, P=0.85).

Conclusions CPAP, compared with conventional oxygen therapy, reduced the composite outcome of intubation or death within 30 days of randomisation in hospitalized adults with acute respiratory failure due to COVID-19. There was no effect observed, compared with conventional oxygen therapy, with the use of HFNO.

(Funded by the UK National Institute for Health Research; ISRCTN 16912075).

Competing Interest Statement

This study is funded by the National Institute for Health Research (NIHR) [COVID-19-RSC]. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Professor Perkins is supported as an NIHR senior investigator, through the NIHR West Midlands Applied Research Collaboration. Professor McAuley is programme director for the NIHR Efficacy and Mechanism Evaluation programme. Professor Perkins and Dr Connolly, are directors of research for the Intensive Care Society. Professor McAuley was, until recently (term ended June 2021), a director of research for the Intensive Care Society Professor Dark is NIHR CRN National Specialty Cluster Lead and is also supported by the Manchester NIHR Biomedical Research Centre. Mrs Devrell reports personal fees from the NIHR for patient and public involvement work related to the study. Outside of the submitted work, the following conflicts of interest were declared. Dr Connolly reports grant funding from the NIHR and personal fees from Fisher and Paykel. Dr Dave reports personal fees from Chesei. Professor De Soyza reports grant support, speakers fees, advisory board fees and conference attendance support from AstraZeneca, Bayer, Chiesi, Gilead, GlaxoSmithKline, Pfizer, Forest labs, Novartis, Insmed, and Zambon. Professor Hart reports grant funding from the NIHR, UK Research and Innovation, with unrestricted grants and equipment from Philips-Respironics, Fisher and Paykel, and Resmed; financial support from Philips for development of the MYOTRACE technology that has patent approved in Europe and US; personal fees for lecturing from Philips-Respironics, Philips, Resmed, and Fisher and Paykel; and institutional funding for his role on the Philips Global Medical Advisory Board. Dr Messer reports personal fees from Fisher and Paykel. Dr Parekh reports grant funding from the NIHR and Medical Research Council UK Research and Innovation. Professor Steiner reports personal fees from GlaxoSmithKline. Professor McAuley reports personal fees from consultancy for GlaxoSmithKline, Boehringer Ingelheim, Bayer, Novartis, SOBI and Eli Lilly, and from sitting on DMECs for trials undertaken by Vir Biotechnology and Faron Pharmaceuticals. Professor McAuley also reports grant funding to his institution from several funders (NIHR, Wellcome Trust, Innovate UK, Medical Research Council, and Northern Ireland Health and Social Research and Development division) for studies in patients with ARDS and COVID-19, and a patent (US8962032) issued to his institution as a treatment for inflammatory disease. The remaining authors report no conflicts of interest.

Clinical Trial

ISRCTN 16912075

Clinical Protocols

https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04617-3

Funding Statement

This study is funded by the National Institute for Health Research (NIHR) [COVID-19-RSC]. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. Professor Perkins is supported as an NIHR senior investigator, through the NIHR West Midlands Applied Research Collaboration. Professor McAuley is programme director for the NIHR Efficacy and Mechanism Evaluation programme. Professor Perkins and Dr Connolly, are directors of research for the Intensive Care Society. Professor McAuley was, until recently (term ended June 2021), a director of research for the Intensive Care Society Professor Dark is NIHR CRN National Specialty Cluster Lead and is also supported by the Manchester NIHR Biomedical Research Centre.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

London-Brighton & Sussex Research Ethics Committee

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All the data are included in the manuscript and available upon requests.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 04, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19
Gavin D Perkins, Chen Ji, Bronwen A Connolly, Keith Couper, Ranjit Lall, J Kenneth Baillie, Judy M Bradley, Paul Dark, Chirag Dave, Anthony De Soyza, Anna V Dennis, Anne Devrell, Sara Fairbairn, Hakim Ghani, Ellen A Gorman, Christopher A Green, Nicholas Hart, Siew Wan Hee, Zoe Kimbley, Shyam Madathil, Nicola McGowan, Benjamin Messer, Jay Naisbitt, Chloe Norman, Dhruv Parekh, Emma M Parkin, Jaimin Patel, Scott E Regan, Clare Ross, Anthony J Rostron, Mohammad Saim, Anita K Simonds, Emma Skilton, Nigel Stallard, Michael Steiner, Rama Vancheeswaran, Joyce Yeung, Daniel F McAuley
medRxiv 2021.08.02.21261379; doi: https://doi.org/10.1101/2021.08.02.21261379
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19
Gavin D Perkins, Chen Ji, Bronwen A Connolly, Keith Couper, Ranjit Lall, J Kenneth Baillie, Judy M Bradley, Paul Dark, Chirag Dave, Anthony De Soyza, Anna V Dennis, Anne Devrell, Sara Fairbairn, Hakim Ghani, Ellen A Gorman, Christopher A Green, Nicholas Hart, Siew Wan Hee, Zoe Kimbley, Shyam Madathil, Nicola McGowan, Benjamin Messer, Jay Naisbitt, Chloe Norman, Dhruv Parekh, Emma M Parkin, Jaimin Patel, Scott E Regan, Clare Ross, Anthony J Rostron, Mohammad Saim, Anita K Simonds, Emma Skilton, Nigel Stallard, Michael Steiner, Rama Vancheeswaran, Joyce Yeung, Daniel F McAuley
medRxiv 2021.08.02.21261379; doi: https://doi.org/10.1101/2021.08.02.21261379

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Intensive Care and Critical Care Medicine
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1099)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9781)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2317)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (605)
  • Hematology (238)
  • HIV/AIDS (506)
  • Infectious Diseases (except HIV/AIDS) (11655)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (239)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2146)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (365)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (147)
  • Palliative Medicine (50)
  • Pathology (312)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2187)
  • Public and Global Health (4672)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)